Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf inhibitors for the treatment of cancer

Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf inhibitors for the treatment of cancer

US Patent 12187703 · Granted Jan 7, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aminopyridine derivatives and their use as selective ALK-2 inhibitors2025
Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[B]py2025
Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[b]py2024
Sacubitril calcium salts2023
Pharmaceutical compositions of lipoic acid choline ester salts and methods of tr2023
Pharmaceutical compositions of lipoic acid choline ester salts and methods of tr2023
Crystalline forms of a triazolopyrimidine compound2023
Pharmaceutical compositions of lipoic acid choline ester salts and methods of tr2021
Pharmaceutical compositions of lipoic acid choline ester salts and methods of tr2021
Crystalline forms of a triazolopyrimidine compound2021
Compositions and methods for modulating farnesoid X receptors2021
Aminopyridine derivatives and their use as selective ALK-2 inhibitors2021